The meningitis belt of sub-Saharan Africa and meningococcal serogroup A conjugate vaccine (MACV) rollout, 2010–2016.

Meningococcal conjugate vaccines: optimizing global impact

Terranella A
Cohn A
Clark T

September 2011

Andrew Terranella1,2, Amanda Cohn2, Thomas Clark2 1Epidemic Intelligence Service, Division of Applie...

The Diversity of Meningococcal Carriage Across the African Meningitis Belt and the Impact of Vaccination With a Group A Meningococcal Conjugate Vaccine.

MenAfriCar consortium

October 2015

BACKGROUND: Study of meningococcal carriage is essential to understanding the epidemiology of Neisse...

Emergence of epidemic Neisseria meningitidis serogroup C in Niger, 2015: an analysis of national surveillance data.

Sidikou, Fati
Zaneidou, Maman
Alkassoum, Ibrahim
Schwartz, Stephanie
Issaka, Bassira
Obama, Ricardo
Lingani, Clement
Tate, Ashley
Ake, Flavien
Sakande, Souleymane
Ousmane, Sani
Zanguina, Jibir
Seidou, Issaka
Nzeyimana, Innocent
Mounkoro, Didier
Abodji, Oubote
Wang, Xin
Taha, Muhamed-Kheir
Moulia-Pelat, Jean Paul
Pana, Assimawe
Kadade, Goumbi
Ronveaux, Olivier
Novak, Ryan
Oukem-Boyer, Odile Ouwe Missi
Meyer, Sarah

August 2016

International audienceTo combat Neisseria meningitidis serogroup A epidemics in the meningitis belt ...

Emergence of serogroup X meningococcal disease in Africa: Need for a vaccine

Xie, Ouli
Pollard, Andrew
Mueller, Judith E.
Norheim, Gunnstein

June 2013

International audienceNeisseria meningitidis is responsible for the seasonal burden and recurrent ep...

Emergence of serogroup X meningococcal disease in Africa: need for a vaccine.

Xie, O
Pollard, AJ
Mueller, JE
Norheim, G

June 2013

Neisseria meningitidis is responsible for the seasonal burden and recurrent epidemics of meningitis ...

Efficacy and Effectiveness of the Meningococcal Conjugate Group A Vaccine MenAfriVac<sup>®</sup> in Preventing Recurrent Meningitis Epidemics in Sub-Saharan Africa

Simonetta Viviani

April 2022

For more than a century, epidemic meningococcal disease mainly caused by serogroup A Neisseria menin...

Priorities for research on meningococcal disease and the impact of serogroup A vaccination in the African meningitis belt

Altmann, Danny
Aseffa, Abraham
Bash, Margaret
Basta, Nicole
Borrow, Ray
Broome, Claire
Caugant, Dominique
Clark, Tom
Collard, Jean-Marc
Djingarey, Mamoudou
Goldblatt, David
Greenwood, Brian
Griffiths, Ulla
Hajjeh, Rana
Hassan-King, Musa
Hugonnet, Stephane
Kimball, Ann Marie
LaForce, Marc
MacLennan, Calman
Maiden, Martin C. J.
Manigart, Olivier
Mayer, Leonard
Messonnier, Nancy
Moisi, Jennifer
Moore, Katie
Moto, Daugla Doumagoum
Mueller, Judith
Nascimento, Maria
Obaro, Stephen
Ouedraogo, Rasmata
Page, Anne-Laure
Perea, Willima
Pluschke, Gerd
Preziosi, Mari-Pierre
Sow, Samba
Stephens, David
Stuart, James
Thomson, Madeleiene
Tiendrebeogo, Sylvestre
Trape, Jean-Francois
Vernet, Guy

January 2013

For over 100 years, large epidemics of meningococcal meningitis have occurred every few years in are...

Evaluation of Serogroup A Meningococcal Vaccines in Africa: A Demonstration Project

Soriano-Gabarró, Montse
Rosenstein, Nancy
LaForce, F. Marc

March 2014

Endemic and epidemic meningococcal disease constitutes a major public-health problem in African coun...

Meningococcal carriage in the African meningitis belt

Ali, O.
Aseffa, A.
Bedru, A.
Lemma, T.
Moti, T.
Worku, A.
Xabher, H. G.
Yamuah, L.
Boukary, R. M.
Collard, J. M.
Dano, I. D.
Habiboulaye, I.
Issaka, B.
Jusot, J. F.
Ousmane, S.
Rabe, I.
Clark, T.
Mayer, L.
Gami, J. P.
Gamougam, K.
Kodbesse, B.
Naibei, N.
Ngadoua, C.
Mbainadji, L.
Moto, D. D.
Narbe, M.
Toralta, J.
Berthe, A.
Keita, M.
Diallo, K.
Onwuchekwa, U.
Sow, S. O.
Tamboura, B.
Traore, A.
Toure, A.
Amodu, M.
Beida, O.
Gadzama, G.
Omotara, B.
Sambo, Z.
Yahya, S.
Chandramohan, D.
Greenwood, B.
Hassan-King, M.
Manigart, O.
Nascimento, M.
Stuart, J.
Woukeu, A.
Bai, X. L.
Borrow, R.
Findlow, H.
Avalo, S.
Bassene, H.
Diallo, A.
Dieng, M.
Doucouré, S.
Gomis, J. F.
Ndiaye, A.
Sokhna, Cheikh
Trape, Jean-François
Akalifa, B.
Forgor, A.
Hodgson, A.
Osei, I.
Quaye, S.
Williams, J.
Wontuo, P.
Basta, N.
Irving, T.
Trotter, C.
Bennett, J.
Hill, D.
Harrison, O.
Rebbetts, L.
Maiden, M.
Tekletsion, Y.
Watkins, E.

January 2013

A meningococcal serogroup A polysaccharide/tetanus toxoid conjugate vaccine (PsA-TT) (MenAfriVac) is...

Menafrivac, Its Success Against Group A Meningococcus In Sub-Saharan Africa And The Challenges Which Lie Ahead.

Leonard F. Leader (7962509)

January 2018

The Sahel is a vast region of semi-arid desert stretching across the south central latitudes of Nort...

African Meningitis Belt, 2004–2013

Olivier Ronveaux Johannes C. Schnitzler

August 2016

Background. An enhanced meningitis surveillance network was established across the meningitis belt o...

Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community trial

Daugla, D M
Gami, J P
Gamougam, K
Naibei, N
Mbainadji, L
Narbé, M
Toralta, J
Kodbesse, B
Ngadoua, C
Coldiron, M E
Fermon, F
Page, A-L
Djingarey, M H
Hugonnet, S
Harrison, O B
Rebbetts, L S
Tekletsion, Y
Watkins, E R
Hill, D
Caugant, D A
Chandramohan, D
Hassan-King, M
Manigart, O
Nascimento, M
Woukeu, A
Trotter, C
Stuart, J M
Maiden, M C J
Greenwood, B M

September 2013

A serogroup A meningococcal polysaccharide-tetanus toxoid conjugate vaccine (PsA-TT, MenAfriVac) was...

Bacterial meningitis epidemiology and return of Neisseria meningitidis serogroup A cases in Burkina Faso in the five years following MenAfriVac mass vaccination campaign.

Alpha Oumar Diallo
Heidi M Soeters
Issaka Yameogo
Guetawendé Sawadogo
Flavien Aké
Clément Lingani
Xin Wang
Andre Bita
Amadou Fall
Lassana Sangaré
Rasmata Ouédraogo-Traoré
Isaïe Medah
Brice Bicaba
Ryan T Novak
MenAfriNet Consortium

January 2017

Historically, Neisseria meningitidis serogroup A (NmA) caused large meningitis epidemics in sub-Saha...

PLoS One

BackgroundHistorically, Neisseria meningitidis serogroup A (NmA) caused large meningitis epidemics i...

BMC Infect Dis

BackgroundThe conjugate vaccine against serogroup A Neisseria meningitidis (NmA), MenAfriVac, is cur...

Meningococcal conjugate vaccines: optimizing global impact

Terranella A
Cohn A
Clark T

September 2011

Andrew Terranella1,2, Amanda Cohn2, Thomas Clark2 1Epidemic Intelligence Service, Division of Applie...

The Diversity of Meningococcal Carriage Across the African Meningitis Belt and the Impact of Vaccination With a Group A Meningococcal Conjugate Vaccine.

MenAfriCar consortium

October 2015

BACKGROUND: Study of meningococcal carriage is essential to understanding the epidemiology of Neisse...

Emergence of epidemic Neisseria meningitidis serogroup C in Niger, 2015: an analysis of national surveillance data.

Sidikou, Fati
Zaneidou, Maman
Alkassoum, Ibrahim
Schwartz, Stephanie
Issaka, Bassira
Obama, Ricardo
Lingani, Clement
Tate, Ashley
Ake, Flavien
Sakande, Souleymane
Ousmane, Sani
Zanguina, Jibir
Seidou, Issaka
Nzeyimana, Innocent
Mounkoro, Didier
Abodji, Oubote
Wang, Xin
Taha, Muhamed-Kheir
Moulia-Pelat, Jean Paul
Pana, Assimawe
Kadade, Goumbi
Ronveaux, Olivier
Novak, Ryan
Oukem-Boyer, Odile Ouwe Missi
Meyer, Sarah

August 2016

International audienceTo combat Neisseria meningitidis serogroup A epidemics in the meningitis belt ...

Emergence of serogroup X meningococcal disease in Africa: Need for a vaccine

Xie, Ouli
Pollard, Andrew
Mueller, Judith E.
Norheim, Gunnstein

June 2013

International audienceNeisseria meningitidis is responsible for the seasonal burden and recurrent ep...

Emergence of serogroup X meningococcal disease in Africa: need for a vaccine.

Xie, O
Pollard, AJ
Mueller, JE
Norheim, G

June 2013

Neisseria meningitidis is responsible for the seasonal burden and recurrent epidemics of meningitis ...

Efficacy and Effectiveness of the Meningococcal Conjugate Group A Vaccine MenAfriVac<sup>®</sup> in Preventing Recurrent Meningitis Epidemics in Sub-Saharan Africa

Simonetta Viviani

April 2022

For more than a century, epidemic meningococcal disease mainly caused by serogroup A Neisseria menin...

Priorities for research on meningococcal disease and the impact of serogroup A vaccination in the African meningitis belt

Altmann, Danny
Aseffa, Abraham
Bash, Margaret
Basta, Nicole
Borrow, Ray
Broome, Claire
Caugant, Dominique
Clark, Tom
Collard, Jean-Marc
Djingarey, Mamoudou
Goldblatt, David
Greenwood, Brian
Griffiths, Ulla
Hajjeh, Rana
Hassan-King, Musa
Hugonnet, Stephane
Kimball, Ann Marie
LaForce, Marc
MacLennan, Calman
Maiden, Martin C. J.
Manigart, Olivier
Mayer, Leonard
Messonnier, Nancy
Moisi, Jennifer
Moore, Katie
Moto, Daugla Doumagoum
Mueller, Judith
Nascimento, Maria
Obaro, Stephen
Ouedraogo, Rasmata
Page, Anne-Laure
Perea, Willima
Pluschke, Gerd
Preziosi, Mari-Pierre
Sow, Samba
Stephens, David
Stuart, James
Thomson, Madeleiene
Tiendrebeogo, Sylvestre
Trape, Jean-Francois
Vernet, Guy

January 2013

For over 100 years, large epidemics of meningococcal meningitis have occurred every few years in are...

Evaluation of Serogroup A Meningococcal Vaccines in Africa: A Demonstration Project

Soriano-Gabarró, Montse
Rosenstein, Nancy
LaForce, F. Marc

March 2014

Endemic and epidemic meningococcal disease constitutes a major public-health problem in African coun...

Meningococcal carriage in the African meningitis belt

Ali, O.
Aseffa, A.
Bedru, A.
Lemma, T.
Moti, T.
Worku, A.
Xabher, H. G.
Yamuah, L.
Boukary, R. M.
Collard, J. M.
Dano, I. D.
Habiboulaye, I.
Issaka, B.
Jusot, J. F.
Ousmane, S.
Rabe, I.
Clark, T.
Mayer, L.
Gami, J. P.
Gamougam, K.
Kodbesse, B.
Naibei, N.
Ngadoua, C.
Mbainadji, L.
Moto, D. D.
Narbe, M.
Toralta, J.
Berthe, A.
Keita, M.
Diallo, K.
Onwuchekwa, U.
Sow, S. O.
Tamboura, B.
Traore, A.
Toure, A.
Amodu, M.
Beida, O.
Gadzama, G.
Omotara, B.
Sambo, Z.
Yahya, S.
Chandramohan, D.
Greenwood, B.
Hassan-King, M.
Manigart, O.
Nascimento, M.
Stuart, J.
Woukeu, A.
Bai, X. L.
Borrow, R.
Findlow, H.
Avalo, S.
Bassene, H.
Diallo, A.
Dieng, M.
Doucouré, S.
Gomis, J. F.
Ndiaye, A.
Sokhna, Cheikh
Trape, Jean-François
Akalifa, B.
Forgor, A.
Hodgson, A.
Osei, I.
Quaye, S.
Williams, J.
Wontuo, P.
Basta, N.
Irving, T.
Trotter, C.
Bennett, J.
Hill, D.
Harrison, O.
Rebbetts, L.
Maiden, M.
Tekletsion, Y.
Watkins, E.

January 2013

A meningococcal serogroup A polysaccharide/tetanus toxoid conjugate vaccine (PsA-TT) (MenAfriVac) is...

Menafrivac, Its Success Against Group A Meningococcus In Sub-Saharan Africa And The Challenges Which Lie Ahead.

Leonard F. Leader (7962509)

January 2018

The Sahel is a vast region of semi-arid desert stretching across the south central latitudes of Nort...

African Meningitis Belt, 2004–2013

Olivier Ronveaux Johannes C. Schnitzler

August 2016

Background. An enhanced meningitis surveillance network was established across the meningitis belt o...

Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community trial

Daugla, D M
Gami, J P
Gamougam, K
Naibei, N
Mbainadji, L
Narbé, M
Toralta, J
Kodbesse, B
Ngadoua, C
Coldiron, M E
Fermon, F
Page, A-L
Djingarey, M H
Hugonnet, S
Harrison, O B
Rebbetts, L S
Tekletsion, Y
Watkins, E R
Hill, D
Caugant, D A
Chandramohan, D
Hassan-King, M
Manigart, O
Nascimento, M
Woukeu, A
Trotter, C
Stuart, J M
Maiden, M C J
Greenwood, B M

September 2013

A serogroup A meningococcal polysaccharide-tetanus toxoid conjugate vaccine (PsA-TT, MenAfriVac) was...

Bacterial meningitis epidemiology and return of Neisseria meningitidis serogroup A cases in Burkina Faso in the five years following MenAfriVac mass vaccination campaign.

Alpha Oumar Diallo
Heidi M Soeters
Issaka Yameogo
Guetawendé Sawadogo
Flavien Aké
Clément Lingani
Xin Wang
Andre Bita
Amadou Fall
Lassana Sangaré
Rasmata Ouédraogo-Traoré
Isaïe Medah
Brice Bicaba
Ryan T Novak
MenAfriNet Consortium

January 2017

Historically, Neisseria meningitidis serogroup A (NmA) caused large meningitis epidemics in sub-Saha...

PLoS One

BackgroundHistorically, Neisseria meningitidis serogroup A (NmA) caused large meningitis epidemics i...

BMC Infect Dis

BackgroundThe conjugate vaccine against serogroup A Neisseria meningitidis (NmA), MenAfriVac, is cur...

Meningococcal conjugate vaccines: optimizing global impact

Terranella A
Cohn A
Clark T

September 2011

Andrew Terranella1,2, Amanda Cohn2, Thomas Clark2 1Epidemic Intelligence Service, Division of Applie...

The Diversity of Meningococcal Carriage Across the African Meningitis Belt and the Impact of Vaccination With a Group A Meningococcal Conjugate Vaccine.

MenAfriCar consortium

October 2015

BACKGROUND: Study of meningococcal carriage is essential to understanding the epidemiology of Neisse...

Emergence of epidemic Neisseria meningitidis serogroup C in Niger, 2015: an analysis of national surveillance data.

Sidikou, Fati
Zaneidou, Maman
Alkassoum, Ibrahim
Schwartz, Stephanie
Issaka, Bassira
Obama, Ricardo
Lingani, Clement
Tate, Ashley
Ake, Flavien
Sakande, Souleymane
Ousmane, Sani
Zanguina, Jibir
Seidou, Issaka
Nzeyimana, Innocent
Mounkoro, Didier
Abodji, Oubote
Wang, Xin
Taha, Muhamed-Kheir
Moulia-Pelat, Jean Paul
Pana, Assimawe
Kadade, Goumbi
Ronveaux, Olivier
Novak, Ryan
Oukem-Boyer, Odile Ouwe Missi
Meyer, Sarah

August 2016

International audienceTo combat Neisseria meningitidis serogroup A epidemics in the meningitis belt ...

The meningitis belt of sub-Saharan Africa and meningococcal serogroup A conjugate vaccine (MACV) rollout, 2010–2016.

Abstract

Extracted data

The meningitis belt of sub-Saharan Africa and meningococcal serogroup A conjugate vaccine (MACV) rollout, 2010–2016.

Abstract

Extracted data

Related items

Related items